These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 25431082

  • 1. Platycodin D induces tumor growth arrest by activating FOXO3a expression in prostate cancer in vitro and in vivo.
    Zhou R, Lu Z, Liu K, Guo J, Liu J, Zhou Y, Yang J, Mi M, Xu H.
    Curr Cancer Drug Targets; 2015; 14(9):860-71. PubMed ID: 25431082
    [Abstract] [Full Text] [Related]

  • 2. Platycodin D, a metabolite of Platycodin grandiflorum, inhibits highly metastatic MDA-MB-231 breast cancer growth in vitro and in vivo by targeting the MDM2 oncogene.
    Kong Y, Lu ZL, Wang JJ, Zhou R, Guo J, Liu J, Sun HL, Wang H, Song W, Yang J, Xu HX.
    Oncol Rep; 2016 Sep; 36(3):1447-56. PubMed ID: 27432230
    [Abstract] [Full Text] [Related]

  • 3. S-equol, a Secondary Metabolite of Natural Anticancer Isoflavone Daidzein, Inhibits Prostate Cancer Growth In Vitro and In Vivo, Though Activating the Akt/FOXO3a Pathway.
    Lu Z, Zhou R, Kong Y, Wang J, Xia W, Guo J, Liu J, Sun H, Liu K, Yang J, Mi M, Xu H.
    Curr Cancer Drug Targets; 2016 Sep; 16(5):455-65. PubMed ID: 26638886
    [Abstract] [Full Text] [Related]

  • 4. Platycodin D induces apoptosis and triggers ERK- and JNK-mediated autophagy in human hepatocellular carcinoma BEL-7402 cells.
    Li T, Xu XH, Tang ZH, Wang YF, Leung CH, Ma DL, Chen XP, Wang YT, Chen Y, Lu JJ.
    Acta Pharmacol Sin; 2015 Dec; 36(12):1503-13. PubMed ID: 26592509
    [Abstract] [Full Text] [Related]

  • 5. T63, a new 4-arylidene curcumin analogue, induces cell cycle arrest and apoptosis through activation of the reactive oxygen species-FOXO3a pathway in lung cancer cells.
    Liu H, Zhou BH, Qiu X, Wang HS, Zhang F, Fang R, Wang XF, Cai SH, Du J, Bu XZ.
    Free Radic Biol Med; 2012 Dec 15; 53(12):2204-17. PubMed ID: 23085518
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of the anticancer and anti-metastasis effects of novel synthetic sodium channel blockers in prostate cancer cells in vitro and in vivo.
    Wang J, Lu Z, Wu C, Li Y, Kong Y, Zhou R, Shi K, Guo J, Li N, Liu J, Song W, Wang H, Zhu M, Xu H.
    Prostate; 2019 Jan 15; 79(1):62-72. PubMed ID: 30242862
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Histone Deacetylase (HDAC) Inhibitor, Suberoylanilide Hydroxamic Acid (SAHA), Induces Apoptosis in Prostate Cancer Cell Lines via the Akt/FOXO3a Signaling Pathway.
    Shi XY, Ding W, Li TQ, Zhang YX, Zhao SC.
    Med Sci Monit; 2017 Dec 06; 23():5793-5802. PubMed ID: 29211704
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inter-regulation of IGFBP1 and FOXO3a unveils novel mechanism in ursolic acid-inhibited growth of hepatocellular carcinoma cells.
    Yang LJ, Tang Q, Wu J, Chen Y, Zheng F, Dai Z, Hann SS.
    J Exp Clin Cancer Res; 2016 Mar 31; 35():59. PubMed ID: 27036874
    [Abstract] [Full Text] [Related]

  • 11. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
    Li A, Wang J, Wu M, Zhang X, Zhang H.
    Eur J Pharmacol; 2015 Jan 15; 747():71-87. PubMed ID: 25498792
    [Abstract] [Full Text] [Related]

  • 12. Platycodin D (PD) regulates LncRNA-XIST/miR-335 axis to slow down bladder cancer progression in vitro and in vivo.
    Chen D, Chen T, Guo Y, Wang C, Dong L, Lu C.
    Exp Cell Res; 2020 Nov 01; 396(1):112281. PubMed ID: 32919956
    [Abstract] [Full Text] [Related]

  • 13. Experimental therapy of human prostate cancer by inhibiting MDM2 expression with novel mixed-backbone antisense oligonucleotides: in vitro and in vivo activities and mechanisms.
    Wang H, Yu D, Agrawal S, Zhang R.
    Prostate; 2003 Feb 15; 54(3):194-205. PubMed ID: 12518324
    [Abstract] [Full Text] [Related]

  • 14. Ziyuglycoside II induces cell cycle arrest and apoptosis through activation of ROS/JNK pathway in human breast cancer cells.
    Zhu X, Wang K, Zhang K, Zhu L, Zhou F.
    Toxicol Lett; 2014 May 16; 227(1):65-73. PubMed ID: 24680927
    [Abstract] [Full Text] [Related]

  • 15. Platycodin D inhibits tumor growth by antiangiogenic activity via blocking VEGFR2-mediated signaling pathway.
    Luan X, Gao YG, Guan YY, Xu JR, Lu Q, Zhao M, Liu YR, Liu HJ, Fang C, Chen HZ.
    Toxicol Appl Pharmacol; 2014 Nov 15; 281(1):118-24. PubMed ID: 25250884
    [Abstract] [Full Text] [Related]

  • 16. Estrogen receptor β upregulates FOXO3a and causes induction of apoptosis through PUMA in prostate cancer.
    Dey P, Ström A, Gustafsson JÅ.
    Oncogene; 2014 Aug 14; 33(33):4213-25. PubMed ID: 24077289
    [Abstract] [Full Text] [Related]

  • 17. Synergistic suppression of prostatic cancer cells by coexpression of both murine double minute 2 small interfering RNA and wild-type p53 gene in vitro and in vivo.
    Ji K, Wang B, Shao YT, Zhang L, Liu YN, Shao C, Li XJ, Li X, Hu JD, Zhao XJ, Xu DQ, Li Y, Cai L.
    J Pharmacol Exp Ther; 2011 Jul 14; 338(1):173-83. PubMed ID: 21444629
    [Abstract] [Full Text] [Related]

  • 18. Triptonide acts as a novel antiprostate cancer agent mainly through inhibition of mTOR signaling pathway.
    Dong F, Yang P, Wang R, Sun W, Zhang Y, Wang A, Chen M, Chen L, Zhang C, Jiang M.
    Prostate; 2019 Aug 14; 79(11):1284-1293. PubMed ID: 31212374
    [Abstract] [Full Text] [Related]

  • 19. Anti-neoplastic activity of low-dose endothelial-monocyte activating polypeptide-II results from defective autophagy and G2/M arrest mediated by PI3K/Akt/FoxO1 axis in human glioblastoma stem cells.
    Liu J, Liu L, Xue Y, Meng F, Li S, Wang P, Liu Y.
    Biochem Pharmacol; 2014 Jun 15; 89(4):477-89. PubMed ID: 24792437
    [Abstract] [Full Text] [Related]

  • 20. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.
    Chun J, Kim YS.
    Chem Biol Interact; 2013 Oct 05; 205(3):212-21. PubMed ID: 23867902
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.